Literature DB >> 31639855

International Council for Standardization in Haematology Recommendations for Hemostasis Critical Values, Tests, and Reporting.

Robert C Gosselin1, Dorothy Adcock2, Akbar Dorgalaleh3, Emmanuel J Favaloro4, Giuseppe Lippi5, João M Pego6, Irene Regan7, Virginie Siguret8.   

Abstract

This guidance document was prepared on behalf of the International Council for Standardization in Haematology (ICSH), the aim of which is to provide hemostasis-related guidance documents for clinical laboratories. The current ICSH document was developed by an ad hoc committee, comprising an international collection of both clinical and laboratory experts. The purpose of this ICSH document is to provide laboratory guidance for (1) identifying hemostasis (coagulation) tests that have potential patient risk based on analysis, test result, and patient presentations, (2) critical result thresholds, (3) acceptable reporting and documenting mechanisms, and (4) developing laboratory policies. The basis for these recommendations was derived from published data, expert opinion, and good laboratory practice. The committee realizes that regional and local regulations, institutional stakeholders (e.g., physicians, laboratory personnel, hospital managers), and patient types (e.g., adults, pediatric, surgical) will be additional confounders for a given laboratory in generating a critical test list, critical value thresholds, and policy. Nevertheless, we expect this guidance document will be helpful as a framework for local practice. Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Entities:  

Mesh:

Year:  2019        PMID: 31639855     DOI: 10.1055/s-0039-1697677

Source DB:  PubMed          Journal:  Semin Thromb Hemost        ISSN: 0094-6176            Impact factor:   4.180


  4 in total

1.  Quantitatively monitoring acute ischemic stroke patients post recombinant tissue plasminogen activator treatment.

Authors:  Yonge Liu; Jingting Ma; Qiyang Shi; Shimeng Xin; Haojia Yu; Zilong Liu; Chunsong Pang; Feng Dong; Jinghan Wang
Journal:  Health Sci Rep       Date:  2020-12-21

Review 2.  Pediatric Fibrinogen PART II-Overview of Indications for Fibrinogen Use in Critically Ill Children.

Authors:  Gemma Louise Crighton; Elise J Huisman
Journal:  Front Pediatr       Date:  2021-04-21       Impact factor: 3.418

3.  Evaluation of the Atellica COAG 360 coagulation analyzer in a specialized coagulation laboratory.

Authors:  Karin Strandberg; Cecilia Augustsson
Journal:  J Clin Lab Anal       Date:  2022-02-11       Impact factor: 2.352

Review 4.  Point-of-Care Diagnostics in Coagulation Management.

Authors:  Sebastian D Sahli; Julian Rössler; David W Tscholl; Jan-Dirk Studt; Donat R Spahn; Alexander Kaserer
Journal:  Sensors (Basel)       Date:  2020-07-30       Impact factor: 3.576

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.